Biomedical Research Day Jan. 6
Biomedical Research Day will be held from 10:45 a.m. to 4 p.m., Tuesday, Jan. 6, 2015, in the CARE/Crawley Building and the UC Medical Sciences Building.
The event is targeting undergraduate students who may be interested in exploring biomedical research opportunities at the University of Cincinnati.
A morning graduate fair will feature current students and representatives of the UC College of Medicine and Cincinnati Childrens Hospital Medical Center graduate programs who will be available to talk about their programs and answer questions. There will also be opportunities to learn about the Summer Undergraduate Research Fellowship (SURF) Program, and David Plas, PhD, associate professor in the department of cancer biology, will present "New Opportunities in Biomedical Science from the Perspective of Cancer Research.
A number of afternoon demonstrations and a workshop for professors and high school AP biology teachers will be held in the afternoon. For more information, contact Lisa Griffith at (513) 558-5626 or griffilt@ucmail.uc.edu.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.